Cargando…

The inhibition of checkpoint activation by telomeres does not involve exclusion of dimethylation of histone H4 lysine 20 (H4K20me2)

DNA double-strand breaks (DSBs) activate the DNA damage checkpoint machinery to pause or halt the cell cycle.  Telomeres, the specific DNA-protein complexes at linear eukaryotic chromosome ends, are capped DSBs that do not activate DNA damage checkpoints.  This “checkpoint privileged” status of telo...

Descripción completa

Detalles Bibliográficos
Autores principales: Audry, Julien, Wang, Jinyu, Eisenstatt, Jessica R., Berkner, Kathleen L., Runge, Kurt W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240467/
https://www.ncbi.nlm.nih.gov/pubmed/30498568
http://dx.doi.org/10.12688/f1000research.15166.2
_version_ 1783371633949409280
author Audry, Julien
Wang, Jinyu
Eisenstatt, Jessica R.
Berkner, Kathleen L.
Runge, Kurt W.
author_facet Audry, Julien
Wang, Jinyu
Eisenstatt, Jessica R.
Berkner, Kathleen L.
Runge, Kurt W.
author_sort Audry, Julien
collection PubMed
description DNA double-strand breaks (DSBs) activate the DNA damage checkpoint machinery to pause or halt the cell cycle.  Telomeres, the specific DNA-protein complexes at linear eukaryotic chromosome ends, are capped DSBs that do not activate DNA damage checkpoints.  This “checkpoint privileged” status of telomeres was previously investigated in the yeast  Schizosaccharomyces pombelacking the major double-stranded telomere DNA binding protein Taz1. Telomeric DNA repeats in cells lacking Taz1 are 10 times longer than normal and contain single-stranded DNA regions. DNA damage checkpoint proteins associate with these damaged telomeres, but the DNA damage checkpoint is not activated. This severing of the DNA damage checkpoint signaling pathway was reported to stem from exclusion of histone H4 lysine 20 dimethylation (H4K20me2) from telomeric nucleosomes in both wild type cells and cells lacking Taz1.  However, experiments to identify the mechanism of this exclusion failed, prompting our re-evaluation of H4K20me2 levels at telomeric chromatin.  In this short report, we used an extensive series of controls to identify an antibody specific for the H4K20me2 modification and show that the level of this modification is the same at telomeres and internal loci in both wild type cells and those lacking Taz1.  Consequently, telomeres must block activation of the DNA Damage Response by another mechanism that remains to be determined.
format Online
Article
Text
id pubmed-6240467
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-62404672018-11-28 The inhibition of checkpoint activation by telomeres does not involve exclusion of dimethylation of histone H4 lysine 20 (H4K20me2) Audry, Julien Wang, Jinyu Eisenstatt, Jessica R. Berkner, Kathleen L. Runge, Kurt W. F1000Res Research Note DNA double-strand breaks (DSBs) activate the DNA damage checkpoint machinery to pause or halt the cell cycle.  Telomeres, the specific DNA-protein complexes at linear eukaryotic chromosome ends, are capped DSBs that do not activate DNA damage checkpoints.  This “checkpoint privileged” status of telomeres was previously investigated in the yeast  Schizosaccharomyces pombelacking the major double-stranded telomere DNA binding protein Taz1. Telomeric DNA repeats in cells lacking Taz1 are 10 times longer than normal and contain single-stranded DNA regions. DNA damage checkpoint proteins associate with these damaged telomeres, but the DNA damage checkpoint is not activated. This severing of the DNA damage checkpoint signaling pathway was reported to stem from exclusion of histone H4 lysine 20 dimethylation (H4K20me2) from telomeric nucleosomes in both wild type cells and cells lacking Taz1.  However, experiments to identify the mechanism of this exclusion failed, prompting our re-evaluation of H4K20me2 levels at telomeric chromatin.  In this short report, we used an extensive series of controls to identify an antibody specific for the H4K20me2 modification and show that the level of this modification is the same at telomeres and internal loci in both wild type cells and those lacking Taz1.  Consequently, telomeres must block activation of the DNA Damage Response by another mechanism that remains to be determined. F1000 Research Limited 2018-10-09 /pmc/articles/PMC6240467/ /pubmed/30498568 http://dx.doi.org/10.12688/f1000research.15166.2 Text en Copyright: © 2018 Audry J et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Note
Audry, Julien
Wang, Jinyu
Eisenstatt, Jessica R.
Berkner, Kathleen L.
Runge, Kurt W.
The inhibition of checkpoint activation by telomeres does not involve exclusion of dimethylation of histone H4 lysine 20 (H4K20me2)
title The inhibition of checkpoint activation by telomeres does not involve exclusion of dimethylation of histone H4 lysine 20 (H4K20me2)
title_full The inhibition of checkpoint activation by telomeres does not involve exclusion of dimethylation of histone H4 lysine 20 (H4K20me2)
title_fullStr The inhibition of checkpoint activation by telomeres does not involve exclusion of dimethylation of histone H4 lysine 20 (H4K20me2)
title_full_unstemmed The inhibition of checkpoint activation by telomeres does not involve exclusion of dimethylation of histone H4 lysine 20 (H4K20me2)
title_short The inhibition of checkpoint activation by telomeres does not involve exclusion of dimethylation of histone H4 lysine 20 (H4K20me2)
title_sort inhibition of checkpoint activation by telomeres does not involve exclusion of dimethylation of histone h4 lysine 20 (h4k20me2)
topic Research Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240467/
https://www.ncbi.nlm.nih.gov/pubmed/30498568
http://dx.doi.org/10.12688/f1000research.15166.2
work_keys_str_mv AT audryjulien theinhibitionofcheckpointactivationbytelomeresdoesnotinvolveexclusionofdimethylationofhistoneh4lysine20h4k20me2
AT wangjinyu theinhibitionofcheckpointactivationbytelomeresdoesnotinvolveexclusionofdimethylationofhistoneh4lysine20h4k20me2
AT eisenstattjessicar theinhibitionofcheckpointactivationbytelomeresdoesnotinvolveexclusionofdimethylationofhistoneh4lysine20h4k20me2
AT berknerkathleenl theinhibitionofcheckpointactivationbytelomeresdoesnotinvolveexclusionofdimethylationofhistoneh4lysine20h4k20me2
AT rungekurtw theinhibitionofcheckpointactivationbytelomeresdoesnotinvolveexclusionofdimethylationofhistoneh4lysine20h4k20me2
AT audryjulien inhibitionofcheckpointactivationbytelomeresdoesnotinvolveexclusionofdimethylationofhistoneh4lysine20h4k20me2
AT wangjinyu inhibitionofcheckpointactivationbytelomeresdoesnotinvolveexclusionofdimethylationofhistoneh4lysine20h4k20me2
AT eisenstattjessicar inhibitionofcheckpointactivationbytelomeresdoesnotinvolveexclusionofdimethylationofhistoneh4lysine20h4k20me2
AT berknerkathleenl inhibitionofcheckpointactivationbytelomeresdoesnotinvolveexclusionofdimethylationofhistoneh4lysine20h4k20me2
AT rungekurtw inhibitionofcheckpointactivationbytelomeresdoesnotinvolveexclusionofdimethylationofhistoneh4lysine20h4k20me2